<DOC>
	<DOCNO>NCT00530504</DOCNO>
	<brief_summary>The purpose study : 1 . To provide additional safety effectiveness information commercial use Protégé™ GPS™ Protégé™ RX Carotid Stent Systems SpiderFX™ Embolic Protection Device . 2 . To evaluate rare unanticipated adverse event . 3 . To evaluate physician level experience carotid artery stenting procedure adverse event rate .</brief_summary>
	<brief_title>Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study</brief_title>
	<detailed_description />
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>18 year Informed consent Intent use PROTÉGÉ™ GPS™ PROTÉGÉ™ RX SpiderFX™ treat carotid artery disease per Instructions Use Meet Instruction Use ( IFU ) / Centers Medicare &amp; Medicaid Services ( CMS ) define anatomical clinical high risk criterion Subjects contraindication outline Instructions Use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Carotid Artery Disease</keyword>
	<keyword>Embolic Protection</keyword>
</DOC>